Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 18/20 | 0.79 |
| ▸ | BCL2 | P10415 | 16/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28475394 | 1.00 | BCL2L1 (0.79) | BCL2L1BCL2 | |
| SCHEMBL25963424 | 0.90 | BCL2L1 (0.78) | BCL2L1BCL2 | |
| SCHEMBL20306172 | 0.90 | BCL2L1 (0.78) | BCL2L1BCL2 | |
| SCHEMBL554094 | 0.88 | BCL2L1 (1.00) | BCL2L1BCL2 | |
| SCHEMBL19263461 | 0.88 | BCL2L1 (0.84) | BCL2L1BCL2 | |
| SCHEMBL30777653 | 0.88 | BCL2L1 (1.00) | BCL2L1BCL2 | |
| SCHEMBL554095 | 0.88 | BCL2L1 (1.00) | BCL2L1BCL2 | |
| SCHEMBL25423836 | 0.85 | BCL2L1 (0.94) | BCL2L1BCL2 | |
| SCHEMBL10058370 | 0.85 | BCL2L1 (0.74) | BCL2L1BCL2 | |
| SCHEMBL25423839 | 0.85 | BCL2L1 (0.94) | BCL2L1BCL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626439-A2 | METHODS OF TREATING ACUTE MYELOID LEUKEMIA | The Regents of the University of Colorado, a body corporate (US) | 2025-10-08 | — | — | EP | disclosed |
| WO-2024119090-A2 | METHODS OF TREATING ACUTE MYELOID LEUKEMIA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2024-06-06 | — | — | WO | disclosed |
| CN-111801320-A | Benzamide compounds | 里科瑞尔姆IP控股有限责任公司 | 2020-10-20 | — | — | CN | disclosed |